By Sue Reisinger | September 27, 2018
"There is much to do, with many opportunities ahead, and I look forward to rolling up my sleeves and working with the executive team to build the business,” Partridge said in a statement.
By Scott Graham | September 13, 2018
Valeant's attempt to disqualify a team of Katten Muchin Rosenman patent litigators led to a showdown Wednesday at the Federal Circuit.
By Kristen Rasmussen | September 12, 2018
Lori Braender, who has been with Day Pitney since she graduated from law school in 1983, will lead the legal functions for the Warren, New Jersey-based company, which is advancing a pipeline of treatment for central nervous system diseases.
By Kristen Rasmussen | September 12, 2018
Alpharetta-based Clearside Biomedical, which specializes in the development of treatments to restore and preserve vision for people with serious eye diseases, has named Leslie Zacks as general counsel and chief compliance officer.
By Sue Reisinger | August 28, 2018
The hire is part of a personnel shift in the legal department that occurred after Novartis' former GC was found to have signed a contract with former Trump lawyer Michael Cohen.
By Kristen Rasmussen | August 14, 2018
Vanda, which has brought on Timothy Williams, specializes in drugs to treat schizophrenia and the "Non-24" sleep disorder.
By Sue Reisinger | July 30, 2018
The British drug company said in an SEC filing that the investigation is tied to allegations made against the company in a private lawsuit filed last year by U.S. veterans and their survivors.
By Sue Reisinger | July 26, 2018
Kesselman will head up Purdue's legal department as it fights off hundreds of lawsuits over the pharma company's role in the ongoing national opioid crisis.
By Kristen Rasmussen | July 20, 2018
The hiring of Austin Kim as GC comes just a few months after the U.S. Food and Drug Administration said it is re-evaluating ACADIA's Nuplazid, the only drug approved to treat hallucinations and delusions associated with Parkinson's disease psychosis.
The Legal Intelligencer | News
By Max Mitchell | July 11, 2018
Overconfident statements Walgreens officials made as its proposed merger with Rite Aid began to show signs of crumbling possibly misled shareholders, a federal judge has ruled in declining to dismiss a shareholder class action suit against the pharmacy company.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS